Illnesses, Deaths Spur FDA Warning on Hepatitis C Drugs
FRIDAY, Oct. 23, 2015 (HealthDay News) — Reports of deaths and illnesses occurring soon after use are prompting the U.S. Food and Drug Administration to issue warnings on two drugs used to fight the hepatitis C virus. The drugs, called Viekira Pak and Technivie, appeared linked to serious liver damage in patients with advanced… Read More »